UCB is a global biopharmaceutical company focused on creating value for people living with severe diseases in immunology and neurology now and into the future.
We are unwavering in our purpose: delivering moments that matter for people impacted by severe diseases, now and into the future. People are at the heart of everything we do, inspiring us, driving our scientific discovery, and leading us to rethink the patient experience. We work with stakeholders to address the unmet needs of patients and caregivers, helping them to achieve their goals and to live the lives they want. UCB is on a journey to be the patient-preferred biopharma leader by delivering medicines and solutions that improve lives while creating value for society.
